Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol for Chronic Oral Food Refusal in Children
NCT03815019Phase 4Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Aug 2019
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of megestrol in Feeding disorder of infancy or early childhood (ARFID), sponsored by University of Kansas Medical Center. Started Aug 2019; status: completed.
02
Drugs
megestrol
03
Conditions
Feeding disorder of infancy or early childhood (ARFID)
Beyond the preview
Go deeper on NCT03815019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03815019.